The propensity of cells to overcome the growth restriction of mutant SAMD9 protein, somatic monosomy 7, 7q deletion or even somatic deletion-nondisjunction mutations are observed in MIRAGE patients with or without any evidence of MDS (2,3). The gene discussed is SAMD9; the disease is myelodysplastic syndrome.